Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma.

IF 1.9 3区医学 Q2 OTORHINOLARYNGOLOGY

European Archives of Oto-Rhino-Laryngology Pub Date : 2024-12-01 Epub Date: 2024-08-31 DOI:10.1007/s00405-024-08882-9

Mercedes Camacho, Cristina Vázquez-López, Cristina Valero, Anna Holgado, Ximena Terra, Francesc Xavier Avilés-Jurado, Xavier León

{"title":"Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma.","authors":"Mercedes Camacho, Cristina Vázquez-López, Cristina Valero, Anna Holgado, Ximena Terra, Francesc Xavier Avilés-Jurado, Xavier León","doi":"10.1007/s00405-024-08882-9","DOIUrl":null,"url":null,"abstract":"Purpose: Glucose is the main energy substrate of tumor cells. This study aims to assess whether the transcriptional expression of glucose metabolism-related genes is associated with occult lymph node metastases in head and neck squamous cell carcinoma (HNSCC) patients.Methods: We examined the transcriptional expression of a panel of glucose metabolism-related genes in a cohort of 53 patients with HNSCC without cervical lymph node involvement at the time of diagnosis (cN0) and subsequently treated with elective neck dissection.Results: Occult lymph node metastases were found in 37.7% (n = 20) of the patients. Among the analyzed genes, SLC16A7 exhibited the strongest association with the presence of occult lymph node metastases. Patients with occult lymph node metastases (cN0/pN +) had significantly lower SLC16A7 expression values (p = 0.001). Patients with low SLC16A7 expression (n = 17, 32.1%) had a frequency of occult lymph node metastases of 76.5%, while for patients with high SLCA16A7 expression (n = 36, 67.9%) it was 19.4% (P = 0.0001). A multivariable analysis showed that patients with low expression of SLC16A7 had a 12.6 times higher risk of developing occult lymph node metastases.Conclusion: cN0 HNSCC patients with low SLC16A7 expression had a higher risk of occult lymph node metastases.","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":" ","pages":"6637-6644"},"PeriodicalIF":1.9000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Archives of Oto-Rhino-Laryngology","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1007/s00405-024-08882-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Glucose is the main energy substrate of tumor cells. This study aims to assess whether the transcriptional expression of glucose metabolism-related genes is associated with occult lymph node metastases in head and neck squamous cell carcinoma (HNSCC) patients.

Methods: We examined the transcriptional expression of a panel of glucose metabolism-related genes in a cohort of 53 patients with HNSCC without cervical lymph node involvement at the time of diagnosis (cN0) and subsequently treated with elective neck dissection.

Results: Occult lymph node metastases were found in 37.7% (n = 20) of the patients. Among the analyzed genes, SLC16A7 exhibited the strongest association with the presence of occult lymph node metastases. Patients with occult lymph node metastases (cN0/pN +) had significantly lower SLC16A7 expression values (p = 0.001). Patients with low SLC16A7 expression (n = 17, 32.1%) had a frequency of occult lymph node metastases of 76.5%, while for patients with high SLCA16A7 expression (n = 36, 67.9%) it was 19.4% (P = 0.0001). A multivariable analysis showed that patients with low expression of SLC16A7 had a 12.6 times higher risk of developing occult lymph node metastases.

Conclusion: cN0 HNSCC patients with low SLC16A7 expression had a higher risk of occult lymph node metastases.

Abstract Image

查看原文本刊更多论文

SLC16A7的转录表达作为头颈部鳞状细胞癌患者隐匿性淋巴结转移的生物标志物。

目的：葡萄糖是肿瘤细胞的主要能量底物。本研究旨在评估葡萄糖代谢相关基因的转录表达是否与头颈部鳞状细胞癌（HNSCC）患者的隐匿性淋巴结转移有关：我们研究了53例诊断时未累及颈淋巴结（cN0）、随后接受选择性颈部清扫术治疗的HNSCC患者体内一组葡萄糖代谢相关基因的转录表达：结果：37.7%的患者（20 人）发现了隐匿性淋巴结转移。在分析的基因中，SLC16A7与隐匿性淋巴结转移的关系最为密切。隐匿性淋巴结转移（cN0/pN +）患者的 SLC16A7 表达值明显较低（p = 0.001）。SLC16A7低表达患者（n = 17，32.1%）发生隐匿性淋巴结转移的频率为76.5%，而SLCA16A7高表达患者（n = 36，67.9%）发生隐匿性淋巴结转移的频率为19.4%（P = 0.0001）。多变量分析显示，SLC16A7表达量低的患者发生隐匿性淋巴结转移的风险是SLC16A7表达量高的患者的12.6倍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Archives of Oto-Rhino-Laryngology 医学-耳鼻喉科学

CiteScore

5.30

自引率

7.70%

发文量

537

审稿时长

2-4 weeks

期刊介绍： Official Journal of European Union of Medical Specialists – ORL Section and Board Official Journal of Confederation of European Oto-Rhino-Laryngology Head and Neck Surgery "European Archives of Oto-Rhino-Laryngology" publishes original clinical reports and clinically relevant experimental studies, as well as short communications presenting new results of special interest. With peer review by a respected international editorial board and prompt English-language publication, the journal provides rapid dissemination of information by authors from around the world. This particular feature makes it the journal of choice for readers who want to be informed about the continuing state of the art concerning basic sciences and the diagnosis and management of diseases of the head and neck on an international level. European Archives of Oto-Rhino-Laryngology was founded in 1864 as "Archiv für Ohrenheilkunde" by A. von Tröltsch, A. Politzer and H. Schwartze.